It could be demonstrated that TfR-targeted immunoliposomes provided a dual targeting effect, as they promoted BBB crossing and subsequent uptake of glioma cells, which are also overexpressing TfR [196]. The gene discussed is TFRC; the disease is central nervous system cancer.